Use of newer-generation drug-releasing stent results in lower rate of adverse cardiac events
Compared with a bare-metal stent, the use of a stent with a biodegradable polymer that releases the drug biolimus resulted in a lower rate of major adverse cardiac events at 1 year among patients with ST-segment elevation ...
Aug 21, 2012
0
0